loadpatents
name:-0.01176905632019
name:-0.005216121673584
name:-0.0087358951568604
Kenderian; Saad Patent Filings

Kenderian; Saad

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kenderian; Saad.The latest application filed is for "treatment of cancer using a cd123 chimeric antigen receptor".

Company Profile
7.5.14
  • Kenderian; Saad - Philadelphia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor
App 20210002377 - Brogdon; Jennifer ;   et al.
2021-01-07
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor
App 20200215171 - Brogdon; Jennifer ;   et al.
2020-07-09
Treatment of cancer using a CD123 chimeric antigen receptor
Grant 10,703,819 - Brogdon , et al.
2020-07-07
Treatment of cancer using a CLL-1 chimeric antigen receptor
Grant 10,568,947 - Brogdon , et al. Feb
2020-02-25
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor
App 20190388471 - June; Carl H. ;   et al.
2019-12-26
Treatment And Prevention Of Cytokine Release Syndrome Using A Chimeric Antigen Receptor In Combination With A Kinase Inhibitor
App 20190336504 - Gill; Saar ;   et al.
2019-11-07
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
Grant 10,357,514 - June , et al. July 23, 2
2019-07-23
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor
App 20180312595 - Brogdon; Jennifer ;   et al.
2018-11-01
Treatment of cancer using a CD123 chimeric antigen receptor
Grant 9,815,901 - Brogdon , et al. November 14, 2
2017-11-14
Treatment Of Cancer Using A Cd33 Chimeric Antigen Receptor
App 20160096892 - Brogdon; Jennifer ;   et al.
2016-04-07
Treatment Of Cancer Using A Cd123 Chimeric Antigen Receptor
App 20160068601 - Brogdon; Jennifer ;   et al.
2016-03-10
Treatment Of Cancer Using A Cll-1 Chimeric Antigen Receptor
App 20160051651 - Brogdon; Jennifer ;   et al.
2016-02-25
Treatment Of Cancer Using Anti-cd19 Chimeric Antigen Receptor
App 20150283178 - June; Carl H. ;   et al.
2015-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed